1. Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, WV;
2. S.C. Ematologia e Trapianto di Midollo Osseo, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy;
3. Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
4. Center for International Blood and Marrow Transplant Research, Department of Medicine and
5. Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI;
6. Division of Hematology/Oncology, Department of Medicine, Emily Couric Clinical Cancer Center, Charlottesville, VA;
7. Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC;
8. Department of Hematology/Oncology, Froedtert Memorial Lutheran Hospital, Milwaukee, WI;
9. South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio, TX;
10. Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom;
11. Blood and Marrow Transplantation, Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS;
12. Department of Haematology, Prince of Wales Hospital, Randwick, NSW, Australia;
13. Department for Stem Cell Transplantation, University Cancer Center, Hamburg, Germany;
14. Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH;
15. Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;
16. Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden;
17. Adult Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
18. Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA;
19. Division of Hematology/Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC;
20. Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL;
21. The International Center for Cell Therapy & Cancer Immunotherapy, Tel Aviv, Israel;
22. Section of Hematology/Oncology, The University of Chicago, Chicago, IL;
23. Servei d’Hematologia, Institut Catala d’Oncologia, Hospital Duran I Reynals, Barcelona, Spain;
24. Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD;
25. Department of Hematology, MD Anderson Cancer Center, Houston, TX;
26. Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
27. Department of Hematology/Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA; and
28. Division of Hematologic Malignancies, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD